158 related articles for article (PubMed ID: 36454866)
1. Identification and validation of DNA methylation markers to predict axillary lymph node metastasis of breast cancer.
Luo J; Chen S; Chen J; Zhou Y; He F; Wang E
PLoS One; 2022; 17(12):e0278270. PubMed ID: 36454866
[TBL] [Abstract][Full Text] [Related]
2. Tumour 18 F-FDG Uptake on preoperative PET/CT may predict axillary lymph node metastasis in ER-positive/HER2-negative and HER2-positive breast cancer subtypes.
Kim JY; Lee SH; Kim S; Kang T; Bae YT
Eur Radiol; 2015 Apr; 25(4):1172-81. PubMed ID: 25298170
[TBL] [Abstract][Full Text] [Related]
3. Predictive factors associated with axillary lymph node metastases in T1a and T1b breast carcinomas: analysis in more than 900 patients.
Rivadeneira DE; Simmons RM; Christos PJ; Hanna K; Daly JM; Osborne MP
J Am Coll Surg; 2000 Jul; 191(1):1-6; discussion 6-8. PubMed ID: 10898177
[TBL] [Abstract][Full Text] [Related]
4. Development and validation of a pre- and intra-operative scoring system that distinguishes between non-advanced and advanced axillary lymph node metastasis in breast cancer with positive sentinel lymph nodes: a retrospective study.
Murata T; Watase C; Shiino S; Kurita A; Ogawa A; Jimbo K; Iwamoto E; Yoshida M; Takayama S; Suto A
World J Surg Oncol; 2022 Sep; 20(1):314. PubMed ID: 36171615
[TBL] [Abstract][Full Text] [Related]
5. Decreased Expression of circ_0000160 in Breast Cancer With Axillary Lymph Node Metastasis.
Wang YW; Chen X; Tian Y; Liu L; Su P
Front Mol Biosci; 2021; 8():690826. PubMed ID: 35211507
[No Abstract] [Full Text] [Related]
6. Axillary lymph node metastasis in pure mucinous carcinoma of breast: clinicopathologic and ultrasonographic features.
Li N; Li JW; Qian Y; Liu YJ; Qi XZ; Chen YL; Gao Y; Chang C
BMC Med Imaging; 2024 May; 24(1):108. PubMed ID: 38745134
[TBL] [Abstract][Full Text] [Related]
7. Development and Validation of a Preoperative Magnetic Resonance Imaging Radiomics-Based Signature to Predict Axillary Lymph Node Metastasis and Disease-Free Survival in Patients With Early-Stage Breast Cancer.
Yu Y; Tan Y; Xie C; Hu Q; Ouyang J; Chen Y; Gu Y; Li A; Lu N; He Z; Yang Y; Chen K; Ma J; Li C; Ma M; Li X; Zhang R; Zhong H; Ou Q; Zhang Y; He Y; Li G; Wu Z; Su F; Song E; Yao H
JAMA Netw Open; 2020 Dec; 3(12):e2028086. PubMed ID: 33289845
[TBL] [Abstract][Full Text] [Related]
8. Risk Stratification For Axillary Lymph Node Metastases in Breast Cancer Patients: What Clinicopathological and Radiological Factors of Primary Breast Cancer Can Predict Preoperatively Axillary Lymph Node Metastases?
Yun SJ; Sohn YM; Seo M
Ultrasound Q; 2017 Mar; 33(1):15-22. PubMed ID: 27428815
[TBL] [Abstract][Full Text] [Related]
9. Nomogram for prediction of level 2 axillary lymph node metastasis in proven level 1 node-positive breast cancer patients.
Jiang Y; Xu H; Zhang H; Ou X; Xu Z; Ai L; Sun L; Liu C
Oncotarget; 2017 Sep; 8(42):72389-72399. PubMed ID: 29069796
[TBL] [Abstract][Full Text] [Related]
10. Predictors of axillary lymph node metastases in patients with T1 breast carcinoma.
Barth A; Craig PH; Silverstein MJ
Cancer; 1997 May; 79(10):1918-22. PubMed ID: 9149018
[TBL] [Abstract][Full Text] [Related]
11. Ultrasonography and clinicopathological features of breast cancer in predicting axillary lymph node metastases.
Xiong J; Zuo W; Wu Y; Wang X; Li W; Wang Q; Zhou H; Xie M; Qin X
BMC Cancer; 2022 Nov; 22(1):1155. PubMed ID: 36352378
[TBL] [Abstract][Full Text] [Related]
12. Frequency and predictors of axillary lymph node metastases in invasive breast cancer.
Chua B; Ung O; Taylor R; Boyages J
ANZ J Surg; 2001 Dec; 71(12):723-8. PubMed ID: 11906387
[TBL] [Abstract][Full Text] [Related]
13. Added Value of MRI for Invasive Breast Cancer including the Entire Axilla for Evaluation of High-Level or Advanced Axillary Lymph Node Metastasis in the Post-ACOSOG Z0011 Trial Era.
Byon JH; Park YV; Yoon JH; Moon HJ; Kim EK; Kim MJ; You JK
Radiology; 2021 Jul; 300(1):46-54. PubMed ID: 33904772
[TBL] [Abstract][Full Text] [Related]
14. Predictors of axillary lymph node metastases (ALNM) in a Korean population with T1-2 breast carcinoma: triple negative breast cancer has a high incidence of ALNM irrespective of the tumor size.
Lee JH; Kim SH; Suh YJ; Shim BY; Kim HK
Cancer Res Treat; 2010 Mar; 42(1):30-6. PubMed ID: 20369049
[TBL] [Abstract][Full Text] [Related]
15. Validation of DNA promoter hypermethylation biomarkers in breast cancer--a short report.
de Groot JS; Pan X; Meeldijk J; van der Wall E; van Diest PJ; Moelans CB
Cell Oncol (Dordr); 2014 Aug; 37(4):297-303. PubMed ID: 25123395
[TBL] [Abstract][Full Text] [Related]
16. Predictive value of pathological and immunohistochemical parameters for axillary lymph node metastasis in breast carcinoma.
Yenidunya S; Bayrak R; Haltas H
Diagn Pathol; 2011 Mar; 6():18. PubMed ID: 21396129
[TBL] [Abstract][Full Text] [Related]
17. Changes in the Ki-67 labeling index between primary breast cancer and metachronous metastatic axillary lymph node: A retrospective observational study.
Ishibashi N; Nishimaki H; Maebayashi T; Hata M; Adachi K; Sakurai K; Masuda S; Okada M
Thorac Cancer; 2019 Jan; 10(1):96-102. PubMed ID: 30375185
[TBL] [Abstract][Full Text] [Related]
18. Correlation Analysis of Pathological Features and Axillary Lymph Node Metastasis in Patients with Invasive Breast Cancer.
Chen H; Meng X; Hao X; Li Q; Tian L; Qiu Y; Chen Y
J Immunol Res; 2022; 2022():7150304. PubMed ID: 36249424
[TBL] [Abstract][Full Text] [Related]
19. The Comparative Study of Ultrasonography, Contrast-Enhanced MRI, and (18)F-FDG PET/CT for Detecting Axillary Lymph Node Metastasis in T1 Breast Cancer.
Hwang SO; Lee SW; Kim HJ; Kim WW; Park HY; Jung JH
J Breast Cancer; 2013 Sep; 16(3):315-21. PubMed ID: 24155761
[TBL] [Abstract][Full Text] [Related]
20. Use of CEA and CA15-3 to Predict Axillary Lymph Node Metastasis in Patients with Breast Cancer.
Wu SG; He ZY; Ren HY; Yang LC; Sun JY; Li FY; Guo L; Lin HX
J Cancer; 2016; 7(1):37-41. PubMed ID: 26722358
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
